PARENTE, Luca
 Distribuzione geografica
Continente #
AS - Asia 7.305
NA - Nord America 6.792
EU - Europa 2.538
SA - Sud America 224
Continente sconosciuto - Info sul continente non disponibili 221
AF - Africa 41
OC - Oceania 9
Totale 17.130
Nazione #
US - Stati Uniti d'America 6.653
HK - Hong Kong 4.476
SG - Singapore 1.237
IT - Italia 869
CN - Cina 716
UA - Ucraina 558
VN - Vietnam 465
DE - Germania 241
RU - Federazione Russa 217
IE - Irlanda 165
BR - Brasile 163
FI - Finlandia 144
FR - Francia 124
KR - Corea 120
CA - Canada 91
TR - Turchia 83
GB - Regno Unito 62
SE - Svezia 58
IN - India 53
AR - Argentina 26
BD - Bangladesh 26
MX - Messico 25
JP - Giappone 21
IQ - Iraq 19
PL - Polonia 16
ID - Indonesia 15
ES - Italia 14
NL - Olanda 14
EU - Europa 12
CZ - Repubblica Ceca 11
CO - Colombia 10
PK - Pakistan 10
ZA - Sudafrica 9
AT - Austria 7
EC - Ecuador 7
JO - Giordania 7
MY - Malesia 7
MA - Marocco 6
PH - Filippine 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
CR - Costa Rica 5
DZ - Algeria 5
MD - Moldavia 5
OM - Oman 5
TN - Tunisia 5
VE - Venezuela 5
BO - Bolivia 4
EG - Egitto 4
ET - Etiopia 4
HU - Ungheria 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PA - Panama 4
CH - Svizzera 3
IL - Israele 3
KZ - Kazakistan 3
LT - Lituania 3
MK - Macedonia 3
RO - Romania 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BG - Bulgaria 2
CL - Cile 2
DK - Danimarca 2
EE - Estonia 2
HN - Honduras 2
JM - Giamaica 2
KE - Kenya 2
MN - Mongolia 2
MZ - Mozambico 2
PE - Perù 2
PY - Paraguay 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BZ - Belize 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
MC - Monaco 1
ME - Montenegro 1
MT - Malta 1
NO - Norvegia 1
PR - Porto Rico 1
Totale 16.914
Città #
Hong Kong 4.472
Ann Arbor 1.197
Singapore 714
Jacksonville 686
San Jose 594
Chandler 576
Princeton 445
Dallas 353
Ashburn 317
Dong Ket 295
Milan 294
Wilmington 264
Council Bluffs 209
Houston 181
Dublin 165
Beijing 137
Nanjing 130
Woodbridge 123
Andover 116
The Dalles 113
Lauterbourg 105
Pellezzano 100
Boardman 98
Rome 83
Salerno 83
Izmir 60
Dearborn 58
Shenyang 51
Hanoi 47
Ho Chi Minh City 45
Ottawa 45
Fairfield 43
Los Angeles 43
Santa Clara 43
Munich 40
Jiaxing 36
New York 36
Changsha 34
Nanchang 30
Hebei 28
Frankfurt am Main 26
Moscow 25
São Paulo 25
Turku 25
Mestre 23
Chicago 22
Düsseldorf 22
Figino 22
Orem 22
Tokyo 21
Denver 20
Tianjin 20
Montreal 19
Norwalk 19
Jinan 17
Falls Church 16
Turin 16
Washington 15
Brooklyn 14
London 14
Warsaw 14
San Diego 13
Atlanta 12
Phoenix 12
Redwood City 12
Chennai 11
Columbus 11
Manchester 11
Stockholm 11
Belo Horizonte 10
Bologna 10
Guangzhou 10
Naples 10
San Francisco 10
Dhaka 9
Napoli 9
Poplar 9
Pune 9
Seattle 9
Amsterdam 8
Boston 8
Cambridge 8
Charlotte 8
Da Nang 8
Mexico City 8
Mumbai 8
Ankara 7
Brno 7
Campinas 7
Hangzhou 7
Jakarta 7
Memphis 7
Seoul 7
Shanghai 7
Baghdad 6
Des Moines 6
Gragnano 6
Helsinki 6
Istanbul 6
Kunming 6
Totale 13.242
Nome #
Histone deacetylase inhibitor FR235222 sensitizes human prostate adenocarcinoma cells to apoptosis through up-regulation of annexin A1. 1.282
Hydrocortisone and 'macrocortin' inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytes. 864
Effects of Prisma® Skin dermal regeneration device containing glycosaminoglycans on human keratinocytes and fibroblasts 630
miR-196a Is Able to Restore the Aggressive Phenotype of Annexin A1 Knock-Out in Pancreatic Cancer Cells by CRISPR/Cas9 Genome Editing 625
Role of Annexin A1 in mouse myoblast cell differentiation 614
Structure-Based Design, Synthesis and Preliminary Anti-inflammatory Activity of Bolinaquinone Analogues 379
Annexin A1 N-Terminal Derived Peptide Ac2-26 Stimulates Fibroblast Migration in High Glucose Conditions. 324
Annexin A1 Induces Skeletal Muscle Cell Migration Acting through Formyl Peptide Receptors. 294
Advances in the pathophysiology of constitutive and inducible cyclooxygenase: two enzymes in the spotlight. 253
Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cells. 244
Dexamethasone inhibits TRAIL-induced apoptosis of thyroid cancer cells via Bcl-xL induction. 223
Evaluation of in situ injectable hydrogels as controlled release device for ANXA1 derived peptide in wound healing 213
14,15-Secopregnane Derivatives from the Leaves of Solenostemma argel. 209
Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway 195
Annexin A1 Contained in Extracellular Vesicles Promotes the Activation of Keratinocytes by Mesoglycan Effects: An Autocrine Loop Through FPRs 191
Annexin A1: Novel Roles in Skeletal Muscle Biology 190
Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid 180
La macrocortina un inibitore della fosfolipasi indotto dai glucocorticoidi 170
Annexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesicles Effects as Evidenced in the In Vitro MIA PaCa-2 Model System 169
Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation 167
The pharmaceutical device prisma® skin promotes in vitro angiogenesis through endothelial to mesenchymal transition during skin wound healing 167
Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. 155
Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: role of annexin A1 153
Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness 151
Annexin 1: more than an antiphospholipase protein 150
ROLE OF ANNEXIN A1 IN MIGRATION OF HUMAN PANCREATIC CARCINOMA CELL LINES 148
R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kB pathway. 147
A new pharmaceutical device containing mesoglycan modulates fibroblasts function in vivo 143
4-Substituted-5-acetyl-2-methyl-6-phenyl-3(2H)pyridazinones as PGE2 and IL-1 release inhibitors from mouse adherent macrophages 142
Annexin-1 downregulation in thyroid cancer correlates to the degree of tumor differentiation 140
Alpha-melanocyte-stimulating hormone reduces interleukin-1 beta effects on rat stomach preparations possibly through interference with a type I receptor. 137
Anti-inflammatory effects of annexin-1: stimulation of IL-10 release and inhibition of nitric oxide synthesis 133
A novel anti-inflammatory peptide from human lipocortin 5. 129
Anaphylactic release of platelet activating factor acether and eicosanoids from lungs of guinea pigs sensitized to ovalbumin aerosol. 123
LGP1 STIMULATES APOPTOSIS IN U937 ASSOCIATED TO INCREASED ANNEXIN A1 PROTEIN EXPRESSION 122
Glucocorticoidi 121
Human eosinophil chemotaxis and selective in vivo recruitment by sphingosine 1-phosphate. 120
Activation of gene expression by interleukin 1. 119
Anti-inflammatory effect of tuftsin and its retro-inverso analogue in rat adjuvant arthritis 119
Studies on cell motility in inflammation. I. The chemotactic activity of experimental, immunological and non-immunological, inflammatory exudates. 114
A comparison of the acute inflammatory response in adrenalectomised and sham-operated rats. 113
The release of interleukin-1-like activity by macrophages in two models of immunological inflammation in the rat. 112
Rectal temperture and prostaglandin E2 increase in cerebrospinal fluid of conscious rabbits after intracerebroventricular injection of hemoglonin. 107
Induction of gene expression by IL-1 in NIH 3T3 cells. Possible requirement of protein kinase C activity and independence from arachidonic acid metabolism. 107
Consensus italiana sulle raccomandazioni EULAR 2005 per il trattamento dell’artrosi dell’anca. 105
Induction of annexin-1 during TRAIL-induced apoptosis in thyroid carcinoma cells 104
5-Lipoxygenase activation may facilitate an interleukin-1 transduction signal. 104
LGP1, a histone deacetylase inhibitor analogue of FR235222, sensitizes promyelocytic leukemia U937 cells to TRAIL-mediated apoptosis 104
Mesoglycan induces the secretion of microvesicles by keratinocytes able to activate human fibroblasts and endothelial cells: A novel mechanism in skin wound healing 103
Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. 102
Consensus italiana sulle raccomandazioni dell’EULAR 2003 per il trattamento dell’artrosi del ginocchio. 102
Farmaci antinfiammatori steroidei 102
Evidence for the neuronal origin of immunoreactive interleukin-1beta released by rat hypothalamic explants. 102
The effect of adrenalectomy on interleukin-1 release in vitro and in vivo. 102
Dexamethasone-induced cytotoxic activity and drug resistance effects in androgen-independent prostate tumor PC-3 cells are mediated by lipocortin 1. 100
Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies 99
Synthetic alleles at position 121 define a functional domain of human interleukin-1beta 98
Modulation of phospholipase A2 activity in human fibroblasts. 98
I GLICOCORTICOIDI 97
Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice. 97
Association between glucocorticoids and lipocortin-1 97
Corticosteroids microparticles produced by supercritical assisted atomization: process optimization, products characterization and “in vitro” performance 96
Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. 96
Gastric antisecretory and anti-ulcer actions of interleukin-1 in rat involve different interleukin-1 receptor types 96
Anti-phospholipase proteins. 94
Immunostimulation by a partially modified retro-inverso-tuftsin analogue containing Thr1 psi[NHCO](R,S)Lys2 modification. 93
Interleukin-1 receptor antagonist displays intrinsic agonist activity on rat gastric fundus motility in vitro 93
The annexin 1-/- mouse. 92
Arachidonic acid lipoxygenation may be involved in interleukin-1 induction of prostaglandin biosynthesis. 92
The effect of steroid treatment on lipocortin immunoreactivity of rat brain 92
Are the lipocortins the second messengers of the anti-inflammatory action of glucocorticoids? 92
Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1. 91
IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as Class II acute phase protein. 91
Identification of several species of phospholipase inhibitory protein(s) by radioimmunoassay for lipomodulin. 91
Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. 89
Proteinase-activated receptor-2 mediates arterial vasodilatation in diabetes 88
Khellin, but not 8-methoxylpsoralen, inhibits adenylyl cyclase system in HeLa cells 88
Peptide 204-212 of lipocortin 5 inhibits the generation of a prostacyclin-like factor from rat aorta preparations in vitro. 87
Prostaglandin E2 and bacterial lipopolysaccharide stimulate bioactive interleukin-1 release from rat hypothalamic explants. 86
Gene structure of the Helicobacter pylori cytotoxin and evidence of its role in gastric disease. 86
The effect of glucocorticoids on lyso-PAF formation in vitro and in vivo. 86
Down-regulation of microglial cyclooxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1. 85
Mechanisms underlying the protective effects of interleukin-1 in experimental NSAID-gastropathy. 85
Evidence that interleukin-1beta and tumor necrosis factor inhibit gastric fundus motility via the 5-lipoxygenase pathway. 83
Induction of annexin-1 at transcriptional and post-transcriptional level in rat brain by methylprednisolone and the 21-aminosteroid U74389F. 83
Sequential release of TNFalfa and phospholipase A2 in a rat model of LPS-induced pleurisy. 83
Pros and cons of selective inhibition of cyclooxygenase-2 versus dual lipoxygenase/cyclooxygenase inhibition: is two better than one? 82
Conceivable difference in the anti-inflammatory mechanisms of lipocortins 1 and 5. 82
Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U-937 cells. 82
Effect of dexamethasone and phorbol myristate acetate on lipocortin 1, 2 and 5 mRNA and protein synthesis. 82
Suppression of arachidonate oxidation by glucocorticoid-induced antiphospholipase peptides. 82
Interleukin-1beta- and tumor necrosis factor-induced inhibition of rat gastric fundus motility in vitro. 79
The cyclo-oxygenase pathway in the avascular heart of the frog, Rana esculenta L. 78
Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteins. 77
Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat. 77
Increase of extracellular brain calcium is involved in interleukin-1beta-induced pyresis in the rabbit; antagonism by dexamethasone 77
Effects of steroids on brain lipocortin immunoreactivity. 76
Cytokines and eicosanoids in cancer drug toxicity. 75
Reduction of aspirin-induced gastric damage in rats by interleukin-1beta: possible involvement of endogenous corticosteroids. 75
Dexamethasone-induced translocation of lipocortin (annexin) 1 to the cell membrane of U-937 cells. 75
Totale 15.641
Categoria #
all - tutte 50.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.323


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022776 0 0 0 13 16 23 6 30 123 110 103 352
2022/20231.388 127 83 18 158 185 298 0 161 243 5 92 18
2023/2024456 50 71 35 22 50 46 29 26 8 19 20 80
2024/20251.121 63 15 9 48 44 126 210 121 155 35 134 161
2025/20268.413 1.851 2.029 1.181 190 515 260 906 144 242 483 90 522
2026/2027271 121 140 10 0 0 0 0 0 0 0 0 0
Totale 17.130